PMVP PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations.

$33.00  +0.28 (0.86%)
As of 04/14/2021 15:59:44 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/25/2020
Outstanding shares:  44,782,566
Average volume:  306,600
Market cap:   $1,465,285,560
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    69353Y103
ISIN:        US69353Y1038
Sedol:      BMW5084
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   4.08
PS ratio:   0.00
Return on equity:   -9.03%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy